1. Home
  2. STN vs ICLR Comparison

STN vs ICLR Comparison

Compare STN & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STN
  • ICLR
  • Stock Information
  • Founded
  • STN 1954
  • ICLR 1990
  • Country
  • STN Canada
  • ICLR Ireland
  • Employees
  • STN N/A
  • ICLR N/A
  • Industry
  • STN Military/Government/Technical
  • ICLR Biotechnology: Commercial Physical & Biological Resarch
  • Sector
  • STN Consumer Discretionary
  • ICLR Health Care
  • Exchange
  • STN Nasdaq
  • ICLR Nasdaq
  • Market Cap
  • STN 12.6B
  • ICLR 14.5B
  • IPO Year
  • STN N/A
  • ICLR 1998
  • Fundamental
  • Price
  • STN $110.86
  • ICLR $175.83
  • Analyst Decision
  • STN
  • ICLR Buy
  • Analyst Count
  • STN 0
  • ICLR 13
  • Target Price
  • STN N/A
  • ICLR $210.67
  • AVG Volume (30 Days)
  • STN 219.0K
  • ICLR 1.2M
  • Earning Date
  • STN 08-13-2025
  • ICLR 10-22-2025
  • Dividend Yield
  • STN 0.41%
  • ICLR N/A
  • EPS Growth
  • STN 29.73
  • ICLR 13.11
  • EPS
  • STN 2.80
  • ICLR 9.73
  • Revenue
  • STN $4,511,386,797.00
  • ICLR $8,089,820,000.00
  • Revenue This Year
  • STN $13.34
  • ICLR N/A
  • Revenue Next Year
  • STN $9.72
  • ICLR $1.73
  • P/E Ratio
  • STN $39.46
  • ICLR $18.06
  • Revenue Growth
  • STN 13.47
  • ICLR N/A
  • 52 Week Low
  • STN $73.18
  • ICLR $125.10
  • 52 Week High
  • STN $113.50
  • ICLR $328.35
  • Technical
  • Relative Strength Index (RSI)
  • STN 58.04
  • ICLR 57.64
  • Support Level
  • STN $105.82
  • ICLR $174.48
  • Resistance Level
  • STN $108.07
  • ICLR $181.51
  • Average True Range (ATR)
  • STN 2.28
  • ICLR 5.15
  • MACD
  • STN -0.03
  • ICLR 0.16
  • Stochastic Oscillator
  • STN 91.04
  • ICLR 78.82

About STN Stantec Inc

Stantec Inc is a sustainable engineering, architecture, and environmental consulting company. It offers services through the following business operating units; Environmental Services, Infrastructure, Water, Buildings, and Energy & Resources. Maximum revenue is derived from its Infrastructure business unit, which is engaged in evaluating, planning, and designing infrastructure solutions for transportation, community development, and urban spaces. The company's reportable segments are the United States, which derives maximum revenue, Canada, and Global. These segments provide consulting in engineering, architecture, interior design, landscape architecture, surveying, environmental sciences, project management, and project economics services in the area of infrastructure and facilities.

About ICLR ICON plc

Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.

Share on Social Networks: